You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Drug

Published Date: 12 May 2025

Revision Summary:
Drug Monograph: Updated Adverse effects section
May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Skin, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Adverse effects section

May 2025
Regimen
Published Date: 07 May 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 06 May 2025
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses section to add: Patients who do not meet the NDFP eligibility criteria may be eligible for compassionate drug access.

May 2025
Regimen
Published Date: 02 May 2025
Cancer Type:
Genitourinary, 
Prostate
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Modified Intent and Rationale/uses section

May 2025
Regimen
Published Date: 01 May 2025
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding, Drug Regimen, and Premedication/Supportive Care sections

May 2025
Regimen
Published Date: 01 May 2025
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Supplementary Public Funding, Drug regimen, and Premedication/Supportive Care sections

May 2025

Pages